SPPH

Spencer Pharmaceutical Inc. SPPH

SPPH
Spencer Pharmaceutical Inc. IMMB
Immunotech Laboratories, Inc. PXYN
Praxsyn Corporation IPAH
Interpharm Holdings, Inc. MHTX
Manhattan Scientifics, Inc. LRDSF
Lords & Company Worldwide Holdings Inc. REFG
Medical Cannabis Payment Solutions, Inc. MEDVF
Medivolve Inc. BIOIF
Biome Grow Inc. CBGL
Cannabis Global, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SPPH IMMB PXYN IPAH MHTX LRDSF REFG MEDVF BIOIF CBGL
6M 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 180.00 %
YTD 0.00 % 0.00 % 0.00 % 0.00 % -88.89 % 0.00 % 0.00 % -66.67 % -92.19 % -6.67 %
1Y 0.00 % 0.00 % 0.00 % 0.00 % -87.50 % 0.00 % 0.00 % -69.23 % -86.84 % 40.00 %
3Y 614.29 % -50.00 % 900.00 % 409 900.00 % -99.00 % -99.32 % -92.86 % -98.71 % -93.54 % -65.00 %
5Y 9 900.00 % 0.00 % -98.00 % 409 900.00 % -99.75 % -100.00 % -99.61 % 3 870.59 % -98.33 % -99.90 %
10Y 9 900.00 % 0.00 % -99.88 % 40 900.00 % -99.85 % -99.98 % -99.82 % 31 874.42 % -99.52 % -99.53 %
From the beginning 9 900.00 % 0.00 % -100.00 % -82.77 % -100.00 % -99.98 % -99.96 % -99.97 % -99.67 % -90.67 %

Dividend